THE LAURA AND JOHN ARNOLD FOUNDATION delivered $7.2 million in grants to address the rising cost of pharmaceutical drugs.
A group advocating for the 340B Drug Discount Program examined the widely held belief that health care organizations enrolled in the controversial federal program receive significantly higher reimbursement for drugs than institutions that do not take part in the program.
At its most recent meeting, in July 2015, the FDA Oncologic Drugs Advisory Committee voted…
MEDICAL ONCOLOGY & HEMATOLOGY ASSOCIATES of Northern Virginia joined the Inova Medical Group. The practice, which brings five physicians, four nurse practitioners or physician assistants, and more than 50 support staff members, will have a brand new outpatient infusion clinic, outpatient pharmacy and lab, and outpatient research facility. The newly named Inova Hematology Oncology will... […]
MARCIA MCNUTT was elected to a six-year term as president of the National Academy of Sciences. McNutt is editor-in-chief of the Science family of journals. William Press, the Warren J. and Viola M. Raymer Professor in the departments of computer science and integrative biology at UT Austin, was elected treasurer. Also, four members were elected... […]
THE CANADIAN CANCER SOCIETY announced four winners of its most prestigious cancer research awards, The Awards for Excellence. Mary Gospodarowicz received the O. Harold Warwick Prize for outstanding achievements in cancer control research. Gospodarowicz is the Princess Margaret Cancer Centre’s medical director and the first Canadian immediate past president of the Union for International Cancer... […]
JEANNIE LEE is the 2016 winner of the Lurie Prize in Biomedical Sciences for uncovering the functions of long, noncoding RNA in epigenetic regulation. Her work was selected by the Foundation for the National Institutes of Health for accelerating the understanding of mechanisms driving epigenetic regulation, which involves changes in gene function without changing the... […]
JOAN SCHILLER was named deputy director of clinical investigation of the Inova Dwight and Martha Schar Cancer Institute. Schiller is the former division chief of Hematology/Oncology at UT Southwestern Medical Center where she lead UTSW’s process to become an NCI-designated cancer center and then an NCI-designated comprehensive center in 2015. She was also deputy director... […]
THE COMMISSION ON CANCER of the American College of Surgeons granted a second installment of 2015 Outstanding Achievement Awards to 27 accredited cancer programs. Award criteria were based on accreditation surveys conducted during the second half of 2015. The award recognizes cancer programs that achieve excellence meeting the CoC Standards. The awardees are: Fairbanks Memorial... […]
PDS Biotechnology signed an Cooperative Research and Development Agreement with NCI to co-develop several immunotherapies through phase II clinical trials to be initiated in 2016 and 2017, utilizing combinations of PDS’s Versamune with NCI- and PDS-sourced tumor-related proteins or their antigens in prostate, breast, and HPV-related cancers. The PDS-NCI CRADA collaboration is led by Jay... […]
